Prevention of vascular dementia. Evidence and practice;Prävention der vaskulären demenz. Evidenz und praxis

Internist

Volumn 53, Issue 2, 2012, Pages 223-231

  Luders S ^a   Stove S ^a   Schrader, J ^a  

^a ST JOSEFS HOSPITAL   (Germany)

Author keywords

Cognitive impairment; Dementia; Dementive diseases; Hypertension; Vascular; Vascular risk factors

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN INFARCTION; CLINICAL PRACTICE; COGNITIVE DEFECT; DIABETES MELLITUS; ECONOMIC ASPECT; HEART ATRIUM FIBRILLATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; MULTIINFARCT DEMENTIA; PREVENTIVE MEDICINE; RISK FACTOR; STROKE;

AGE OF ONSET; ATRIAL FIBRILLATION; CAUSALITY; COMORBIDITY; DEMENTIA, VASCULAR; EVIDENCE-BASED MEDICINE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84863091168     PISSN: 00209554     EISSN: 14321289     Source Type: Journal    
DOI: 10.1007/s00108-011-2953-x     Document Type: Article

References (56)

1. Ball K, Berch DB, Helmers KF et al (2002) Effects of cognitivetraining interventions with older adults: a randomized controlled trial. JAMA 288:2271-2281 (Pubitemid 35291757)
2. Bernick C, Kuller L, Dulberg C et al (2001) Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology 57:1222-1229 (Pubitemid 32947380)
3. Biessels GJ, Staekenborg S, Brunner E et al (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 1:64-74 (Pubitemid 41790697)
4. Bunch TJ, Weiss JP, Crandall BG et al (2010) Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm 7:433-437
5. Bunch TJ, Crandall BG, Weiss JP et al (2011) Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 22:839-845
6. Dufouil C, Godin O, Chalmers J, PROGRESS MRI Substudy Investigators et al (2009) Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke 40:2219-2221
7. Duron E, Rigaud AS, Dubail D et al (2009) Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease. Am J Hypertens 22:1020-1024
8. Eichner JE, Dunn ST, Perveen G et al (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155:487-495 (Pubitemid 34208040)
9. Elias MF, Sullivan LM, D'Agostino RB et al (2004) Framingham stroke risk profile and lowered cognitive performance. Stroke 35:404-409 (Pubitemid 38174420)
10. Etgen T, Sander D, Bickel H et al (2010) Cognitive decline: the relevance of diabetes, hyperlipi-daemia and hypertension. Br J Diabetes Vasc Dis 10:115-122
11. Fogari R, Preti P, Mugellini A et al (2002) Influence of losartan and atenolol on cognitive function in very elderly hypertensive patients. Am J Hypertens 15:36 A
12. Forette F, Seux ML, Staessen JA, Syst-Eur Investigators et al (2002) The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 162:2046-2052 (Pubitemid 35168212)
13. Gorelick PB (2004) Riskfactors for vascular dementia and Alzheimer disease. Stroke 35 (Suppl 1):2620-2622 (Pubitemid 39458352)
14. Gorelick PB, Scuteri A, Black SE et al (2011) Vascular Contributions to Cognitive Impairment and Dementia. A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 42:2672-2713
15. Haag MDM, Hofman A, Koudstaal PJ et al (2009) Duration of antihypertensive drug use and risk of dementia. A prospective cohort study. Neurology 72:1727-1734
16. Hachinski V, Iadecola C, Petersen RC et al (2006) National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37:2220-2241 (Pubitemid 44337162)
17. Hanon O, Haulon S, Lenoir H et al (2005) Relationship between arterial stiffness and cognitive function in elderly subjects with complaints of memory loss. Stroke 36:2193-2197 (Pubitemid 41429244)
18. Inaba S,Iwai M, Furuno M et al (2009)Continuous activation of renin-angiotensin system impairs cognitive function in renin/angiotensinogen transgenic mice. Hypertension 53:356-362
19. Jefferson AL, Himali JJ, Beiser AS et al (2010) Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation 122:690-697
20. Knecht S, Wersching H, Lohmann H et al (2008) High-normal blood pressure is associated with poor cognitive performance. Hypertension 51:663-668 (Pubitemid 351301518)
21. Launer LJ, Masaki K, Petrovitch H et al (1995) The association between midlife blood pressure levels and late-life cognitive function. JAMA 274:1846-1851 (Pubitemid 26001260)
22. Leys D, Henon H, Mackowiak-Cordoliani MA et al (2005) Poststroke dementia. Lancet Neurol 4:752-759 (Pubitemid 41457291)
23. Li NC, Lee A, Whitmer RA et al (2010) Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340:b5465
24. Lüders S, Hammersen F, Kulschewski A et al (2005) Cognitivefunction in hypertensives with elevated stroke risk. Dtsch Med Wochenschr 130 (Suppl 4):S141-S187
25. Morris MC, Scherr PA, Hebert LE et al (2001) Association of incident Alzheimer's disease and blood pressure measured from 13 yrs beforeto 2 yrs after diagnosis in a large community study. Arch Neurol 58:1640-1646 (Pubitemid 32963229)
26. National Institutes of Health Consensus Development Program (2010) NIH State-of-the-science conference: preventing Alzheimer's disease and cognitive decline. http://consensus.nih.gov/2010/alzstatement.htm
27. Ninomiya T, Ohara T, Hirakawa Y et al (2011) Midlife and late-life blood pressure and dementia in Japanese elderly; the Hisayama study. Hypertension 58:22-28
28. Novak V, Hajjar I (2010) The relationship between blood pressure and cognitivefunction. Nat Rev Cardiol 7:686-698
29. O'Donnell MJ, Xavier D, Liu L et al (2010) Risk factors for ischemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376:112-123
30. Otani H, Kikuya M, Hara A et al (2010) Association of kidney dysfunction with silent lacunar infarcts and white matter hyperintensity in the general population: the Ohasama study. Cerebrovasc Dis 30:43-50
31. Pantoni L, Gorelick P (2011) Advances in vascular cognitive impairment 2010. Stroke 42:291-293
32. Peila R, White LR, Masaki K et al (2006) Reducing the risk of dementia. Efficacy of long-term treatment of hypertension. Stroke 37:1165-1170 (Pubitemid 43731856)
33. Peters R, Beckett N, Forette F et al (2008) Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet 7:683-689
34. Plassman BL, Williams JW, Burke JR et al (2010) Systematic review: factors associated with riskfor and possible prevention of cognitive decline in later life. Ann Intern Med 153:182-193
35. Poorthuis RB, Goriounova NA, Couey JJ et al (2009) Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences. Biochem Pharmacol 78:668-676
36. Rusanen M, Kivipelto M, Quesenberry CP Jr et al (2011) Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med 171:333-339
37. Sabia S, Marmot M, Dufouil C et al (2008) Smoking history and cognitive function in middle age from the Whitehall II study. Arch Intern Med 168:1165-1173 (Pubitemid 351831399)
38. Schneider JA, Arvanitakis Z, Bang W et al (2007) Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69:2197-2204 (Pubitemid 350294674)
39. Sierra C, de la Sierra A, Mercader J et al (2002) Silent cerebral white matter lesions in middleaged essential hypertensive patients. J Hypertens 20:519-524 (Pubitemid 34913752)
40. Sink KM, Leng X, Williamson J et al (2009) Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension. Arch Intern Med 169:1195-1202
41. Skoog I, Lernfelt B, Landahl S et al (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141-1145 (Pubitemid 126512042)
42. Skoog I, Nilsson L, Palmertz B et al (1993) A population based study of dementia in 85-years olds. N Engl J Med 328:153-158
43. Stewart R, Xue QL, Masaki K et al (2009) Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension 54:233-240
44. Sturman MT, Morris MC, Mendes de Leon CF et al (2005) Physical activity, cognitive activity, and cognitive decline in a biracial community population. Arch Neurol 62:1750-1754 (Pubitemid 41626673)
45. Sugiyama T, Lee JD, Shimizu H et al (1999) Influence of treated blood pressure on progression of silent cerebral infarction. J Hypertens 17:679-684 (Pubitemid 29243501)
46. Tedesco MA, Ratti G, Mennella S et al (1999) Comparison of losartan and hydrochlorothiazide on cognitivefunction and quality of life in hypertensive patients. Am J Hypertens 12:1130-1134
47. Tu JV (2010) Reducing the global burden of stroke. Lancet 376:74-75
48. Tzourio C, Anderson C, Chapman N et al (2003) Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163:1069-1075 (Pubitemid 36548935)
49. Van Straaten ECW, Scheltens P, Knol DL et al (2003) Operational definitions for the NINDS-AIREN criteria for vascular dementia. An interobserver study. Stroke 34:1907-1912 (Pubitemid 36944779)
50. Verdelho A, Madureira S, Moleiro C, LADIS Study Group et al (2010) White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 75:160-167
51. Vermeer SE, Prins ND, den Heijer T et al (2003) Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348:1215-1222 (Pubitemid 36359297)
52. Waldstein SR, Rice SC, Thayer JF et al (2008) Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension 51:99-104 (Pubitemid 350307110)
53. Watanabe N, Imai Y, Nagai K et al (1996) Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke 27:1319-1327 (Pubitemid 26286161)
54. Watfaa G, Rossignola P, Kearney-Schwartza A et al (2010) Use of calcium channel blockers is associated with better cognitive performance in older hypertensive patients with subjective memory complaints. J Hypertens 28:2485-2493
55. Whitmer RA, Sidney S, Selby J et al (2005) Midlife cardiovascular riskfactors and risk of dementia in late life. Neurology 64:277-281
56. Wright JW, Harding JW (2008) The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease. J Renin Angiotensin Aldosterone Syst 9:226-237